marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-05-2024
Nektar Therapeutics Balance Sheet 2011-2024 | NKTR
Annual Balance Sheet Nektar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
82.5 M | 43.3 M | 118 M | - | 308 M | 1.19 B | 532 M | 513 M | 440 M | 338 M | 284 M | 351 M | 214 M |
Long Term Debt |
98.5 M | 113 M | 126 M | - | - | 247 M | 245 M | 243 M | 242 M | 125 M | 125 M | 125 M | - |
Long Term Debt Current |
19.3 M | 18.7 M | 17.4 M | 13.9 M | 12.5 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 218 M | 351 M | 365 M | 409 M | 434 M | 341 M | 426 M | 372 M | 133 M |
Total Current Liabilities |
51.3 M | 68.2 M | 85.2 M | 116 M | 354 M | 82 M | 56.2 M | 72.2 M | 61.2 M | 64 M | 98.2 M | 78.5 M | 276 M |
Total Liabilities |
267 M | 344 M | 438 M | 461 M | 572 M | 433 M | 421 M | 481 M | 496 M | 405 M | 524 M | 451 M | 409 M |
Deferred Revenue |
- | - | - | - | 5.52 M | 13.9 M | 18.9 M | 14.4 M | 21.4 M | 24.5 M | 23.7 M | 21.9 M | 19.6 M |
Retained Earnings |
-3.48 B | -3.2 B | -2.83 B | -2.31 B | -1.86 B | -1.42 B | -2.12 B | -2.02 B | -1.87 B | -1.79 B | -1.73 B | -1.57 B | -1.4 B |
Total Assets |
398 M | 711 M | 1.12 B | 1.54 B | 1.98 B | 2.15 B | 509 M | 569 M | 502 M | 442 M | 435 M | 498 M | 607 M |
Cash and Cash Equivalents |
35.3 M | 88.2 M | 25.2 M | 199 M | 96.4 M | 195 M | 4.76 M | 59.6 M | 55.6 M | 12.4 M | 39.1 M | 25.4 M | 15.3 M |
Book Value |
131 M | 367 M | 680 M | 1.08 B | 1.41 B | 1.72 B | 87.8 M | 88.1 M | 6.43 M | 36.3 M | -89.9 M | 47 M | 198 M |
Total Shareholders Equity |
131 M | 367 M | 680 M | 1.08 B | 1.41 B | 1.72 B | 87.8 M | 88.1 M | 6.43 M | 36.3 M | -89.9 M | 47 M | 198 M |
All numbers in USD currency
Quarterly Balance Sheet Nektar Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | 116 M | - | 123 M | 126 M | 129 M | 132 M | 135 M | 136 M | 136 M | 136 M | 136 M | 143 M | 143 M | 143 M | 143 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 134 M | 135 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | 369 M | - | 416 M | 438 M | 476 M | 466 M | 462 M | 461 M | 461 M | 461 M | 461 M | 572 M | 572 M | 572 M | 572 M | 433 M | 433 M | 433 M | 433 M | 421 M | 421 M | 421 M | 421 M | 481 M | 481 M | 481 M | 481 M | 492 M | 492 M | 492 M | 492 M | 405 M | 405 M | 405 M | 405 M | 524 M | 524 M | 524 M | 524 M | 451 M | 451 M | 451 M | 451 M | 409 M | 409 M | 409 M | 409 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | 91 K | 507 K | 1.76 M | 3.01 M | 5.52 M | 5.52 M | 5.52 M | 5.52 M | 13.9 M | 13.9 M | 13.9 M | 19.5 M | 18.9 M | 25.5 M | 13.4 M | 24.2 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 23.7 M | 23.7 M | 23.7 M | 23.7 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M |
Retained Earnings |
- | -3.14 B | - | -2.92 B | -2.83 B | -2.69 B | -2.56 B | -2.43 B | -2.31 B | -2.31 B | -2.31 B | -2.31 B | -1.86 B | -1.86 B | -1.86 B | -1.86 B | -1.42 B | -1.42 B | -1.42 B | -1.42 B | -2.12 B | -2.12 B | -2.12 B | -2.12 B | -2.02 B | -2.02 B | -2.02 B | -2.02 B | -1.87 B | -1.87 B | -1.87 B | -1.87 B | -1.79 B | -1.79 B | -1.79 B | -1.79 B | -1.73 B | -1.73 B | -1.73 B | -1.73 B | -1.57 B | -1.57 B | -1.57 B | -1.57 B | -1.4 B | -1.4 B | -1.4 B | -1.4 B |
Total Assets |
- | 781 M | - | 1.02 B | 1.12 B | 1.28 B | 1.37 B | 1.46 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B | 2.15 B | 2.15 B | 2.15 B | 2.15 B | 509 M | 509 M | 509 M | 509 M | 569 M | 569 M | 569 M | 569 M | 499 M | 499 M | 499 M | 499 M | 442 M | 442 M | 442 M | 442 M | 435 M | 435 M | 435 M | 435 M | 498 M | 498 M | 498 M | 498 M | 607 M | 607 M | 607 M | 607 M |
Cash and Cash Equivalents |
- | 106 M | - | 68 M | 25.2 M | 54 M | 152 M | 150 M | 199 M | 199 M | 199 M | 199 M | 96.4 M | 96.4 M | 96.4 M | 96.4 M | 195 M | 195 M | 195 M | 195 M | 4.76 M | 4.76 M | 4.76 M | 4.76 M | 59.6 M | 59.6 M | 59.6 M | 59.6 M | 55.6 M | 55.6 M | 55.6 M | 55.6 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 39.1 M | 39.1 M | 39.1 M | 39.1 M | 25.4 M | 25.4 M | 25.4 M | 25.4 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M |
Book Value |
- | 412 M | - | 608 M | 680 M | 802 M | 905 M | 995 M | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.41 B | 1.41 B | 1.41 B | 1.41 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 87.8 M | 87.8 M | 87.8 M | 87.8 M | 88.1 M | 88.1 M | 88.1 M | 88.1 M | 6.43 M | 6.43 M | 6.43 M | 6.43 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | -89.9 M | -89.9 M | -89.9 M | -89.9 M | 47 M | 47 M | 47 M | 47 M | 198 M | 198 M | 198 M | 198 M |
Total Shareholders Equity |
- | 412 M | - | 608 M | 680 M | 802 M | 905 M | 995 M | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.41 B | 1.41 B | 1.41 B | 1.41 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 87.8 M | 87.8 M | 87.8 M | 87.8 M | 88.1 M | 88.1 M | 88.1 M | 88.1 M | 6.43 M | 6.43 M | 6.43 M | 6.43 M | 36.3 M | 36.3 M | 36.3 M | 36.3 M | -89.9 M | -89.9 M | -89.9 M | -89.9 M | 47 M | 47 M | 47 M | 47 M | 198 M | 198 M | 198 M | 198 M |
All numbers in USD currency